Categorias DeCS
C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.450 Neoplasms, Connective and Soft Tissue .
C04.557.450.565 Neoplasms, Connective Tissue .
C04.557.450.565.550 Myxoma .
C04.557.450.565.550.312 Carney Complex .
C04.588 Neoplasms by Site .
C04.588.894 Thoracic Neoplasms .
C04.588.894.309 Heart Neoplasms .
C04.588.894.309.500 Carney Complex .
C05 Musculoskeletal Diseases .
C05.116 Bone Diseases .
C05.116.099 Bone Diseases, Developmental .
C05.116.099.370 Dysostoses .
C05.116.099.370.894 Synostosis .
C05.116.099.370.894.232 Craniosynostoses .
C05.116.099.370.894.232.015 Acrocephalosyndactylia .
C05.116.099.370.894.819 Syndactyly .
C05.116.099.370.894.819.100 Acrocephalosyndactylia .
C05.660 Musculoskeletal Abnormalities .
C05.660.207 Craniofacial Abnormalities .
C05.660.207.240 Craniosynostoses .
C05.660.207.240.100 Acrocephalosyndactylia .
C05.660.585 Limb Deformities, Congenital .
C05.660.585.800 Syndactyly .
C05.660.585.800.100 Acrocephalosyndactylia .
C05.660.906 Synostosis .
C05.660.906.364 Craniosynostoses .
C05.660.906.364.100 Acrocephalosyndactylia .
C05.660.906.819 Syndactyly .
C05.660.906.819.100 Acrocephalosyndactylia .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.490 Epilepsy .
C10.228.140.490.375 Epilepsy, Generalized .
C10.228.140.490.375.525 Nodding Syndrome .
C14 Cardiovascular Diseases .
C14.280 Heart Diseases .
C14.280.459 Heart Neoplasms .
C14.280.459.500 Carney Complex .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.077 Abnormalities, Multiple .
C16.131.077.229 Carney Complex .
C16.131.621 Musculoskeletal Abnormalities .
C16.131.621.207 Craniofacial Abnormalities .
C16.131.621.207.240 Craniosynostoses .
C16.131.621.207.240.100 Acrocephalosyndactylia .
C16.131.621.585 Limb Deformities, Congenital .
C16.131.621.585.800 Syndactyly .
C16.131.621.585.800.100 Acrocephalosyndactylia .
C16.131.621.906 Synostosis .
C16.131.621.906.364 Craniosynostoses .
C16.131.621.906.364.100 Acrocephalosyndactylia .
C16.131.621.906.819 Syndactyly .
C16.131.621.906.819.100 Acrocephalosyndactylia .
C16.131.831 Skin Abnormalities .
C16.131.831.108 Carney Complex .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.288 Disease .
C23.550.288.500 Syndrome .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.068 Amino Acids, Basic .
D12.125.068.050 Arginine .
D12.125.068.050.587 Nitroarginine .
D12.125.095 Amino Acids, Diamino .
D12.125.095.104 Arginine .
D12.125.095.104.587 Nitroarginine .
E05 Investigative Techniques .
E05.940 Toxicity Tests .
E05.940.600 No-Observed-Adverse-Effect Level .
G07 Physiological Phenomena .
G07.690 Pharmacological and Toxicological Phenomena .
G07.690.936 Toxicological Phenomena .
G07.690.936.750 No-Observed-Adverse-Effect Level .
Termos Sinônimos e Históricos Documentos LILACS e MDL
Acrocephalosyndactylia . Acrocephalosyndactyly (Apert) . Acrocephalosyndactyly III . Acrocephalosyndactyly, Type 1 . Acrocephalosyndactyly, Type 3 . Acrocephalosyndactyly, Type I . Acrocephalosyndactyly, Type II . Acrocephalosyndactyly, Type III . Acrocephalosyndactyly, Type V . Acrocephaly, Skull Asymmetry, and Mild Syndactyly . Apert-Crouzon Disease . Chotzen Syndrome . Craniofacial-Skeletal-Dermatologic Dysplasia . Dysostosis Craniofacialis with Hypertelorism . Kurczynski Casperson Syndrome . Noack Syndrome . Syndactylic Oxycephaly . Acrocephalosyndactylias . Acrocephalosyndactylies, Type 1 . Acrocephalosyndactylies, Type 3 . Acrocephalosyndactylies, Type I . Acrocephalosyndactylies, Type II . Acrocephalosyndactylies, Type III . Acrocephalosyndactylies, Type V . Acrocephalosyndactyly IIIs . Apert Crouzon Disease . Disease, Apert-Crouzon . Noack Syndromes . Saethre Chotzen Syndrome . Syndactylic Oxycephalies . Syndrome, Apert . Syndrome, Chotzen . Syndrome, Kurczynski Casperson . Syndrome, Noack . Syndrome, Pfeiffer . Syndrome, Saethre-Chotzen . Syndromes, Noack . Type I Acrocephalosyndactylies . Type I Acrocephalosyndactyly . Type II Acrocephalosyndactylies . Type II Acrocephalosyndactyly . Type III Acrocephalosyndactyly . Type V Acrocephalosyndactylies . Type V Acrocephalosyndactyly . Apert Syndrome . Pfeiffer Syndrome . Saethre-Chotzen Syndrome . 1.00
Carney Complex . Carney Complex, Type 1 . Carney Complex, Type I . Carney Myxoma-Endocrine Complex, Type II . LAMB - Lentigines, Atrial Myxoma, Mucocutaneous Myoma, Blue Nevus Syndrome . Nevi, Atrial Myxoma, Skin Myxoma, Ephelides Syndrome . Carney Myxoma Endocrine Complex . Carney Myxoma Endocrine Complex, Type II . Complex, Carney . Complex, Carney Myxoma-Endocrine . LAMB Syndromes . Myxoma-Endocrine Complex, Carney . NAME Syndromes . Syndrome, Carney . Syndrome, LAMB . Syndromes, LAMB . Carney Complex, Type 2 . Carney Complex, Type II . Carney Myxoma-Endocrine Complex . Carney Syndrome . LAMB Syndrome . Myxoma, Spotty Pigmentation, and Endocrine Overactivity . NAME Syndrome . 0.53
No-Observed-Adverse-Effect Level . Acceptable Daily Intake . Tolerable Daily Intake . Acceptable Daily Intakes . Daily Intake, Acceptable . Daily Intake, Tolerable . Daily Intakes, Acceptable . Daily Intakes, Tolerable . Intake, Acceptable Daily . Intake, Tolerable Daily . Intakes, Acceptable Daily . Intakes, Tolerable Daily . Level, No-Observed-Adverse-Effect . Level, No-Observed-Effect . Levels, No-Observed-Adverse-Effect . Levels, No-Observed-Effect . No Observed Adverse Effect Level . No Observed Effect Level . No-Observed-Adverse-Effect Levels . No-Observed-Effect Levels . Tolerable Daily Intakes . No-Observed-Effect Level . NOAEL . 0.50